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Background and purpose: Family history (FH) is used as a marker for inherited
risk. Using FH for this purpose requires the FH to reﬂect true disease in the fam-
ily. The aim was to analyse the concordance between young and middle-aged
ischaemic stroke patients’ reported FH of cardiovascular disease (CVD) with
their parents’ own reports.
Methods: Ischaemic stroke patients aged 15–60 years and their eligible par-
ents were interviewed using a standardized questionnaire. Information of own
CVD and FH of CVD was registered. Concordance between patients and par-
ents was tested by kappa statistics, sensitivity, speciﬁcity, predictive values and
likelihood ratios. Regression analyses were performed to identify patient char-
acteristics associated with non-concordance of replies.
Results: There was no diﬀerence in response rate between fathers and moth-
ers (P = 0.355). Both parents responded in 57 cases. Concordance between
patient and parent reports was good, with kappa values ranging from 0.57 to
0.7. The patient-reported FH yielded positive predictive values of 75% or
above and negative predictive values of 90% or higher. The positive likelihood
ratios (LR+) were 10 or higher and negative likelihood ratios (LR) were gen-
erally 0.5 or lower. Interpretation regarding peripheral arterial disease was lim-
ited due to low parental prevalence. Higher age was associated with impaired
concordance between patient and parent reports (odds ratio 1.05; 95% conﬁ-
dence interval 1.01–1.09; P = 0.020).
Conclusions: The FH provided by young and middle-aged stroke patients is
in good concordance with parental reports. FH is an adequate proxy to assess
inherited risk of CVD in young stroke patients.
Introduction
A positive family history (FH) of cardiovascular
disease (CVD) in ﬁrst-degree relatives confers an
increased risk of stroke and coronary artery disease
(CAD) [1–7]. FH is used as a marker for inherited
risk of disease both for cancer and CVD [8,9]. FH
can serve as a tool in identifying individuals with high
risk of developing CVD, and may aid in risk stratiﬁ-
cation and disease prevention [9–12]. FH is usually
self-reported and the accuracy or validity of such
self-reporting has been tested in various ways, e.g. by
conﬁrmation from medical records and by reports
from patient relatives, with varying accuracy [10,13–
16]. Higher age reduces accuracy, and female sex
seems associated with increased accuracy of FH
reporting [15]. Studies have found that under-report-
ing a FH of cancer is common and may be a problem
when assessing FH as a risk factor [17,18]. Misreport-
ing of FH could introduce bias and lead to misclassiﬁ-
cation of patients with inherited risk, and thereby
hamper the use of FH as a tool to study the heredity
of CVD [15]. The accuracy of FH has predominantly
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been tested in healthy cohorts, with a few exceptions
assessing the accuracy of FH in patients with CAD
[19,20]. The Norwegian Stroke in the Young Study
(NOR-SYS), a prospective population-based study
conducted in a well-deﬁned region of western Norway,
enrols young and middle-aged ischaemic stroke
patients up to 60 years of age. The patients are inter-
viewed regarding FH of stroke, CAD and peripheral
arterial disease (PAD) [21]. NOR-SYS is designed to
evaluate family patterns in the development of vascu-
lar disease using reported events, clinical examinations
(e.g. by ultrasound) and genetic analyses. As this
cohort consists of patients with documented cerebral
infarction, a need to evaluate the accuracy of the
patient-provided FH of CVD became apparent. With
standardized questionnaires sent to all eligible patient
parents providing self-reported disease history, the
aim was to analyse the concordance between patient-
and parent-reported FH.
Subjects and methods
Patients aged 15–60 years admitted to the Stroke
Unit, Department of Neurology at Haukeland
University Hospital, with acute ischaemic stroke
since September 2010 were prospectively included in
NOR-SYS. Acute cerebral infarction was conﬁrmed
by computed tomography or magnetic resonance
imaging.
Patients were interviewed regarding FH of CVD
using a standardized questionnaire, most within 3
days after acute ischaemic stroke was diagnosed (see
Data S1). Only events recalled and reported by the
patient were registered by the interviewing doctor.
The interview was done face-to-face and contact with
family members by mobile phone or in any other way
was avoided. Only patients able to answer without
assistance were included. To increase similarity and
ensure reproducibility, all new interviewers partici-
pated as a bystander in at least ﬁve interviews,
thereby minimizing diﬀerences amongst interviewers.
The questionnaire contained detailed questions
regarding the FH of stroke, CAD and PAD in moth-
ers, fathers, siblings and all four grandparents sepa-
rately. Conﬁrmative answers prompted follow-up
questions to further classify the disease. Patients were
assigned to the educational categories basic school,
high school and college/university education.
Patients were asked if their parents were alive and
able to ﬁll out a similar questionnaire. Based on the
patient’s consent a similar questionnaire was sent to
the parent/parents along with a stamped return enve-
lope. The standardized parent questionnaire recorded
the parent’s own clinical events of CVD, risk factors
and medication, in addition to their parental FH of
CVD (see Data S2).
Statistics
STATA 13.1 (StataCorp, College Station, TX, USA)
was used for analyses. The chi-squared test, Wilcoxon
rank-sum test or Student’s t test was used to compare
diﬀerences in patient and parent demographics, as
appropriate. Spearman’s correlation was used to test
for correlation. Concordance was tested using kappa
statistics. In addition, speciﬁcity, sensitivity, predictive
values and likelihood ratios were calculated by a
STATA module named ‘diagt’, with patient answers
as the diagnostic test and parent reports as the gold
standard [22]. Kappa values of 0.41–0.60 were inter-
preted as moderate, 0.61–0.80 as substantial and
0.81–0.99 as near perfect concordance [23]. Regression
analyses were performed to examine if patient charac-
teristics inﬂuenced concordance. The level of signiﬁ-
cance was set at P < 0.05.
Ethics
All participating patients and patients’ parents gave
informed written consent. The NOR-SYS protocol is
approved by the Regional Ethics Committee of west-
ern Norway, and is conducted in accordance with the
Declaration of Helsinki. The NOR-SYS protocol is
registered at http://www.clinicaltrials.gov with the
unique identiﬁer NCT01597453.
Results
From September 2010 to August 2014, 313 acute
ischaemic stroke patients were included in NOR-SYS.
A ﬂowchart for patient and parent eligibility and
inclusion is presented in Fig. 1. A common reason for
patients refusing the invitation of parents was parent
dementia. However, causes for refusal were not asked
for systematically. No diﬀerences in reply rates were
seen between fathers and mothers (P = 0.355). The
mean age of patients with both parents alive com-
pared with one or more deceased parents was 41.55
and 53.77 years, respectively (SD 10.50 and 6.16,
P < 0.001). The rate of parental reply was similar
between patient sexes with 87 (44.67%) male and 45
(49.5%) female patients having one or more parents
replying (P = 0.402). Spearman’s correlation revealed
a negative correlation between patient age and the
number of parent replies (r = 0.506, P < 0.001),
also present when the number of deceased parents
was adjusted for in a linear regression analysis (P <
0.001). Both parents were alive and responded in 57
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(19.8%) cases. Table 1 shows the demographic data
and presence of risk factors in the 132 patients with
one or more parents replying.
Patient answers were in moderate to substantial
concordance with parental reports, with kappa values
ranging from 0.54 to 0.69 regarding stroke and CAD
(Table 2). The rate of concordance was similar
between parent sexes. The number of incorrect
answers was lowest with regard to parental PAD and
highest for parental CAD. Patient under-reporting of
FH was twice as frequent as false positive FH reports.
Positive predictive values were generally above 70%
and negative predictive values were generally above
90%, except with regard to PAD where prevalence
amongst parents was low (Table 3). Positive likeli-
hood ratios (LR+) were around 10 or higher and neg-
ative likelihood ratios (LR) were generally 0.5 or
less. Regression analyses revealed that increasing
patient age was associated with non-concordance
between patient and parent reports with an odds ratio
of 1.05 per year (95% conﬁdence interval 1.01–1.09;
P = 0.020; Table 4). However, neither patient sex,
level of education, employment status, living status,
alcohol consumption nor smoking signiﬁcantly inﬂu-
enced concordance between patient and parent reports
(Table 4).
Discussion
A high proportion of deceased parents, especially
deceased fathers, was observed, probably due to
longer life expectancy in females and earlier debut of
CVD in males [24,25]. Stroke, CAD and PAD were
reported in 53 (18%), 42 (14%) and 10 (3%) mothers,
and 51 (18%), 93 (32%) and 18 (6%) fathers, respec-
tively (data not shown). The patients had a high
Table 1 Demographic data and presence of risk factors for cardio-
vascular disease in 132 patients included in the Norwegian Stroke in
the Young Study (NOR-SYS)
Patients N = 132
Mean age (SD) 44.5 (11.2)
Higher education (%) 65 (49.2)
Living situation
Alone 26 (19.7)
Partner/family member 106 (80.3)
Institution 1 (0.8)
Employment status
Full-time joba 103 (78.0)
Part-time job 13 (9.8)
Stay at home parent 1 (0.8)
Unemployed 4 (3.0)
Welfare beneﬁtsb 11 (8.3)
Hypertension (%) 41 (31.1)
Diabetes mellitus (%) 5 (3.8)
Overweight (%) 88 (66.7)
Active smoker (%) 49 (37.1)
Alcohol units/week
≤3 or never 83 (62.9)
4–6 29 (22.0)
7–12 11 (8.3)
≥13 9 (6.8)
Higher education, deﬁned as completed college or university educa-
tion; hypertension, deﬁned as current treatment for hypertension; dia-
betes mellitus, deﬁned as treatment for diabetes mellitus, including
both medical and non-medical treatment; overweight, deﬁned as body
mass index >25 kg/m2.aAlso includes self-employed, full-time students
and pupils; bincluding full welfare beneﬁt recipients and partial beneﬁt
recipients if no work was registered. Six cases reporting both partial
welfare beneﬁts and part-time job were registered as part-time job.
288 fathers 288 mothers
185 mothers
156 mothers
112 mothers
115 fathers
100 fathers
77 fathers
Figure 1 Flowchart of patient and par-
ent eligibility and study inclusion.
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burden of traditional vascular risk factors, as shown
in young stroke populations in several European
regions [26]. Concordance between patient and parent
reports was good, especially with regard to stroke and
CAD. The LR+ of 19 with regard to stroke in moth-
ers tells us that a patient report of maternal stroke is
19 times more likely to concur with maternal reports
than to be a false positive report. Correspondingly the
high negative predictive values and the low LR show
that a negative patient-reported FH truly reﬂects no
disease event amongst ﬁrst-degree family members.
Concordance was mostly acceptable also regarding
PAD. However, interpretation was limited by the low
prevalence of parental PAD. The present study shows
no diﬀerence between males and females regarding
non-concordance, indicating that the previously
reported higher frequency of positive FH in females is
not a result of more accurate FH reporting by females
[27]. This supports the previous studies showing no
diﬀerence in accuracy of FH reporting between males
and females [15,28].
Previous studies evaluating the FH of cancer show
substantial under-reporting. In probands with veriﬁed
Table 2 Patient versus parental answers regarding cardiovascular
disease history from 132 patients and 189 parents included in the
Norwegian Stroke in the Young Study (NOR-SYS)
Patients’
answers
Non-concordance (%) Kappa (SD)No Yes
Mothers’ answers
Stroke (n = 110)
No 92 3 9 (8.18) 0.62a (0.09)
Yes 6 9
CAD (n = 107)
No 89 2 10 (9.35) 0.57a (0.09)
Yes 8 8
PAD (n = 106)
No 100 2 6 (5.66) 0.03 (0.09)
Yes 4 0
Fathers’ answers
Stroke (n = 75)
No 61 2 6 (8.00) 0.68a (0.11)
Yes 4 8
CAD (n = 77)
No 49 4 9 (12.99) 0.69a (0.11)
Yes 6 18
PAD (n = 75)
No 71 1 3 (4.00) 0.38a (0.11)
Yes 2 1
CAD, coronary artery disease, deﬁned as either myocardial infarc-
tion or angina pectoris; PAD, peripheral arterial disease, deﬁned as
intermittent claudication or initiated treatment for peripheral arterial
disease. Some patients’ parents did not provide answers to all disease
categories as indicated by the varying number of parent replies.
aP < 0.001.
Table 3 Accuracy of 132 patient reports of cardiovascular parental disease compared with answers from 189 parents included in the Norwe-
gian Stroke in the Young Study (NOR-SYS)
Parent Condition Prevalence PPV (95% CI) NPV (95% CI)
Sensitivity
(95% CI)
Speciﬁcity
(95% CI) LR+ (95% CI) LR (95% CI)
Mother Stroke 13.6% (15/110) 74.9 (48–91) 93.9 (89–97) 60.0 (32–84) 96.8 (91–99) 19.0 (6–62) 0.41 (0.2–0.8)
CAD 14.8% (16/107) 79.8 (48–94) 91.8 (97–94) 50.0 (25–75) 97.8 (92–100) 22.8 (5–97) 0.51 (0.3–0.8)
PAD 3.8% (4/106) NA 96.1 (96–96) NA (0–60) 98.0 (93–100) NA 1.02 (1.0–1.1)
Father Stroke 16.0% (12/75) 80.0 (49–94) 93.8 (87–97) 66.7 (35–90) 96.8 (89–100) 21.0 (5–87) 0.34 (0.2–0.8)
CAD 31.2% (24/77) 81.8 (63–92) 89.1 (79–94) 75.0 (53–90) 92.5 (82–98) 9.9 (4–26) 0.27 (0.1–0.5)
PAD 4.0% (3/75) 50.0 (7–93) 97.3 (94–99) 33.3 (1–91) 98.6 (92–100) 24.0 (2–298) 0.68 (0.3–1.5)
CAD, coronary artery disease, deﬁned as either myocardial infarction or angina pectoris; CI, conﬁdence interval; LR+, positive likelihood ratio
is the quotient of sensitivity/(1  speciﬁcity); LR, negative likelihood ratio is the quotient of (1  sensitivity)/speciﬁcity; NA, not applicable;
NPV, negative predictive value is the number of true negatives/number of negative calls; PAD, peripheral arterial disease, deﬁned as diagnosed
or treated PAD; PPV, positive predictive value is the number of true positives/number of positive calls.
Table 4 Logistic regression analysis displaying factors associated
with non-concordance between patient-reported family history of
CVD and parents’ own reports, from 132 patients and 189 parents
included in the Norwegian Stroke in the Young Study (NOR-SYS)
OR 95% CI P value
Age (years) 1.05 1.01–1.09 0.020
Gender (female) 1.72 0.63–4.72 0.291
Education 0.77 0.42–1.38 0.378
Full-time job (reference)
Part-time job 1.09 0.28–4.37 0.895
Unemployed 0.94 0.09–10.39 0.960
Living with partner (reference)
Living with family member 1.63 0.39–6.77 0.505
Living alone 1.07 0.37–3.07 0.898
Smoking 0.75 0.44–1.26 0.272
Alcohol consumption 0.89 0.57–1.40 0.632
OR, odds ratio; CI, conﬁdence interval; CVD, cardiovascular
disease. Full-time job also included full-time student, pupil and self-
employed; part-time job included one stay at home parent; unem-
ployed also included welfare recipients. Education, three categories:
basic school, gymnasium and college/university. Living with family
member, other than partner, e.g. child or parent.
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colorectal cancer 25% of siblings reported a negative
FH of cancer [17]. Another study reported interviewee
sensitivities of 50%–60% regarding cancer in ﬁrst-
degree relatives [18]. The present study with low rates
of non-concordance shows that under-reporting is
around twice as frequent as over-reporting also
regarding a FH of CVD, meaning that a patient
reports a false negative FH more often than a false
positive. However, the under-reporting of FH of CVD
varies; the NHLBI-FHS compared proband and par-
ent reports and showed 85% sensitivity for parental
CAD and substantial agreement with a kappa value
of 0.76 [15]. A MONICA sub-study verifying proband
reports with medical records showed sensitivities
regarding myocardial infarction in ﬁrst-degree rela-
tives of around 68% with kappa values above 0.65 in
both cases and controls [20]. A study on healthy
undergraduates reported sensitivities of 84.2% with
regard to heart attack and 100% with regard to stroke
in parents. However, due to the low proband age the
numbers of diseased parents was low with only one
reported stroke [29]. The Framingham study reported
sensitivities of 74% for heart attack <55 years and
42% for stroke <65 years [14]. The diﬀerences in
methodology, with some applying age limits on paren-
tal disease and some using medical records to conﬁrm
parental events, probably cause the prevalence dis-
crepancy and impair direct comparison with the pre-
sent results. Diﬀerent methods for obtaining FH and
diﬀerent patient characteristics probably explain the
variations in accuracy. Sending questionnaires by mail
[15] permits obtainment of FH information from fam-
ily members or other sources, thereby increasing accu-
racy and concordance between patient and family
reports. The previously reported association between
young age and high accuracy of reporting [14] is sup-
ported by the present study. Higher patient age was
associated with an incorrect FH report with an odds
ratio of 1.05 per year (P = 0.020). CVD events at
young age tend to be a more dramatic event to the
family involved. These events may therefore be more
vividly remembered and thereby lead to better cross-
generational knowledge of FH. Lastly our cohort con-
sists of patients with veriﬁed ischaemic stroke, which
it was feared would reduce the accuracy of reporting
compared to healthy individuals [2,14,15]. However,
the sensitivities and kappa values in the present study
are comparable with previous results, with 75% sensi-
tivity and a kappa value of 0.69 regarding CAD in
fathers.
The study is strengthened by the questionnaire-
based patient interview enabling control questions and
thereby increasing the accuracy of FH reports. Addi-
tional strengths are the well-deﬁned group of young
and middle-aged patients and the mandatory veriﬁca-
tion of ischaemic stroke. Our study has some limita-
tions. Parent information was used as the gold
standard for disease status. However, the contact
between patients and parents after the patient’s inter-
view was not limited and therefore the possibility of
joint recall bias cannot be excluded. The numbers of
eligible patients and parents were modest, in part
limited by the high numbers of deceased parents. The
study site of one hospital and the geographical catch-
ment area with predominantly Caucasian inhabitants
limits direct generalizability beyond this population.
This study shows that a detailed FH of CVD is
mostly correct when young ischaemic stroke patients
are interviewed in a standardized way by trained med-
ical professionals. Increasing age was the only demo-
graphic factor associated with reduced concordance.
FH is an inexpensive and widely available tool for
evaluating inherited risk; verifying it with parental
reports strengthens its validity [8]. The patient FH can
be used as a proxy for inherited risk of CVD in young
ischaemic stroke patients.
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